22 related articles for article (PubMed ID: 38575828)
1. Colon Cancer Survival Among South Asian Americans: A Cross-Sectional Analysis of a National Dataset.
Ahmed KS; Marcinak CT; LoConte NK; Krebsbach JK; Virani SS; Schiefelbein AM; Varley P; Walker M; Ghias K; Murtaza M; Zafar SN
J Surg Res; 2024 Jul; 299():269-281. PubMed ID: 38788463
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy exacerbates the survival paradox of colon cancer: a propensity score matching analysis.
Tian M; Zhou Z
Transl Cancer Res; 2022 Dec; 11(12):4241-4253. PubMed ID: 36644182
[TBL] [Abstract][Full Text] [Related]
3. Survival paradox between stage IIB/C and stage IIIA colon cancer: is it time to revise the American Joint Committee on Cancer TNM system?
Chu QD; Li T; Hsieh MC; Yi Y; Gibbs JF; Sahawneh J; Sang W; Gallagher J; Wu XC
Surg Endosc; 2024 May; 38(5):2857-2870. PubMed ID: 38575828
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
Kim HS; Kim KM; Lee SB; Kim GR; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
J Surg Oncol; 2019 Sep; 120(3):423-430. PubMed ID: 31134644
[TBL] [Abstract][Full Text] [Related]
5. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
6. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer.
Li H; Fu G; Wei W; Huang Y; Wang Z; Liang T; Tian S; Chen H; Zhang W
Front Oncol; 2020; 10():595107. PubMed ID: 33312954
[TBL] [Abstract][Full Text] [Related]
7. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer.
Chu QD; Zhou M; Medeiros K; Peddi P
Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043
[TBL] [Abstract][Full Text] [Related]
8. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
[TBL] [Abstract][Full Text] [Related]
9. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
Edge SB; Compton CC
Ann Surg Oncol; 2010 Jun; 17(6):1471-4. PubMed ID: 20180029
[TBL] [Abstract][Full Text] [Related]
10. Revised TN categorization for colon cancer based on national survival outcomes data.
Gunderson LL; Jessup JM; Sargent DJ; Greene FL; Stewart AK
J Clin Oncol; 2010 Jan; 28(2):264-71. PubMed ID: 19949014
[TBL] [Abstract][Full Text] [Related]
11. The future of the TNM staging system in colorectal cancer: time for a debate?
Quirke P; Williams GT; Ectors N; Ensari A; Piard F; Nagtegaal I
Lancet Oncol; 2007 Jul; 8(7):651-7. PubMed ID: 17613427
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
O'Connell JB; Maggard MA; Ko CY
J Natl Cancer Inst; 2004 Oct; 96(19):1420-5. PubMed ID: 15467030
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]